Literature DB >> 12168861

Voltage-gated sodium ion channels in prostate cancer: expression and activity.

Mansoor Abdul1, Naseema Hoosein.   

Abstract

BACKGROUND: High levels of voltage-gated sodium channels (VGSCs) have been previously associated with the invasiveness of rat and human prostate cancer (Pca) cell lines.
MATERIALS AND METHODS: 4 normal prostate and 80 clinical Pca specimens on a tissue microarray slide were examined by immunohistochemistry using anti-sodium channel (III-IV linker region) antibody. The effects of a VGSC-opener and VGSC-blockers on the in vitro proliferation of 4 human Pca cell lines was examined.
RESULTS: Fifty-five% (44 out of 80) Pca specimens showed higher VGSC levels compared to normal, with 14 (of 44) showing increased focal staining. VGSC-opener veratrine (1-50 microg/mL), increased growth of PC3, DU145, LNCaP and MDA-PCA-2B Pca cells. VGSC-blockers, flunarizine (IC50=2 microg/mL) and riluzole (IC50=10-30 microg/mL) caused dose-dependent growth-inhibition of all four cell lines. Western analysis of cell extracts showed VGSC-immunoreactivity in the 4 Pca cell lines.
CONCLUSION: Our results indicate increased expression of VGSCs in Pca and VGSC involvement in Pca growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12168861

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  23 in total

Review 1.  Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Authors:  Alina L Capatina; Dimitris Lagos; William J Brackenbury
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

2.  Bioelectric Control of Metastasis in Solid Tumors.

Authors:  Samantha L Payne; Michael Levin; Madeleine J Oudin
Journal:  Bioelectricity       Date:  2019-09-16

Review 3.  Effects of sulfonylureas on tumor growth: a review of the literature.

Authors:  Giulia Pasello; Loredana Urso; Pierfranco Conte; Adolfo Favaretto
Journal:  Oncologist       Date:  2013-09-16

4.  Effects of Hedera helix L. extracts on rat prostate cancer cell proliferation and motility.

Authors:  Hatice Gumushan-Aktas; Seyhan Altun
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

Review 5.  An emerging role for voltage-gated Na+ channels in cellular migration: regulation of central nervous system development and potentiation of invasive cancers.

Authors:  William J Brackenbury; Mustafa B A Djamgoz; Lori L Isom
Journal:  Neuroscientist       Date:  2008-10-20       Impact factor: 7.519

6.  Expression of Voltage-Gated Sodium Channel Nav1.8 in Human Prostate Cancer is Associated with High Histological Grade.

Authors:  Simeng Suy; Todd P Hansen; Heather D Auto; Bhaskar V S Kallakury; Vernon Dailey; Malika Danner; Linda Macarthur; Ying Zhang; Matthew J Miessau; Sean P Collins; Milton L Brown
Journal:  J Clin Exp Oncol       Date:  2012-11-01

7.  Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.

Authors:  Ilknur Bugan; Selma Kucuk; Zeynep Karagoz; Scott P Fraser; Handan Kaya; Andrew Dodson; Christopher S Foster; Seyhan Altun; Mustafa B A Djamgoz
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-03-20       Impact factor: 5.554

Review 8.  Dual roles of voltage-gated sodium channels in development and cancer.

Authors:  Faheemmuddeen Patel; William J Brackenbury
Journal:  Int J Dev Biol       Date:  2015       Impact factor: 2.203

9.  The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells.

Authors:  William J Brackenbury; Athina-Myrto Chioni; James K J Diss; Mustafa B A Djamgoz
Journal:  Breast Cancer Res Treat       Date:  2006-07-13       Impact factor: 4.872

10.  Activity-dependent regulation of voltage-gated Na+ channel expression in Mat-LyLu rat prostate cancer cell line.

Authors:  William J Brackenbury; Mustafa B A Djamgoz
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.